Sugar Hearth

Meet Jardiance: the First Antidiabetic Drug To Reduce Cardiovascular Risk

The obesity epidemic and a progressively more sedentary lifestyle have contributed to type 2 diabetes (T2D) becoming increasingly more common. Cardiovascular (CV) disease is the major cause of mortality among patients with T2D, accounting for 60–80% of deaths in these patients. Despite recent studies demonstrating the benefit of a proper glycemic control in decreasing cardiovascular… Read more »

delivery_resized

Novel Drug Formulation Delivers Immunotherapy To Ovarian Cancer Cells

Ovarian cancer is the fifth most common cancer in women. Worldwide, nearly 239,000 women were diagnosed with ovarian cancer in 2012, with variable incidence rates in different countries. Ovarian cancer becomes more common after menopause; nevertheless the occurrence of ovarian cancer in younger women has increased by 56% in the last 50 years. Early diagnosis… Read more »